Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies

NCT03467152 is registered in ClinicalTrials.gov with Eisai Inc. as lead sponsor.

NCT NCT03467152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03467152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Placebo-Controlled, Double-Blind, Parallel-Group, Randomized, Study To Evaluate the Efficacy, Safety and Tolerability of E2027 in Subjects With Dementia With Lewy Bodies
Lead sponsor
Eisai Inc.
Phase
Phase 2
Overall status
Completed
Start date
May 4, 2018
Completion date
April 15, 2020
Enrollment
326 (actual)
Sites
74

Conditions

As the registry lists them; a condition with its own page is linked.

dementia with lewy bodies